Publications

Publications 2005

TEMOZOLOMIDE (TMZ) COMBINED WITH CISPLATIN (CDDP) IN PATIENTS WITH BRAIN METASTASES FROM SOLID TUMORS: A HELLENIC COOPERATIVE ONCOLOGY GROUP (HeCOG) PHASE II STUDY
C. Christodoulou, D. Bafaloukos, H. Linardou, G. Aravantinos, A. Bamias, M. Carina, G. Klouvas, D. Skarlos
J Neurooncol. 2005 Jan;71(1):61-5


 

POSTOPERATIVE DOSE-DENSE SEQUENTIAL CHEMOTHERAPY WITH EPIRUBICIN, FOLLOWED BY CMF WITH OR WITHOUT PACLITAXEL, IN PETIENTS WITH HIGH-RISK OPERABLE BREAST CANCER: A RANDOMIZED PHASE III STUDY CONDUCTED BY THE HELLENIC COOPERATIVE ONCOLOGY GROUP
G. Fountzilas, D. Skarlos, U. Dafni, H. Gogas, E. Briasoulis, D. Pectasides, Ch. Papadimitriou, Ch. Markopoulos, A. Polychronis, H.P. Kalofonos, V. Siafaka, P. Kosmidis, E. Timotheadou, D. Tsavdaridis, D. Bafaloukos, P. Papakostas, E. Razis, P. Makrantonakis, G. Aravantinos, Ch. Christodoulou, A. M. Dimopoulos
Ann Oncol 2005 Nov;16(11):1762-71


 

CHEMOTHERAPY FOR PATIENTS WITH TWO FAVOURABLE SUBSETS OF UNKNOWN PRIMARY CARCINOMA: ACTIVE, BUT HOW EFFECTIVE?
G. Pentheroudakis, E. Briassoulis, V. Karavassilis, G. Fountzilas, N. Xiros, G. Samelis, E. Samantas & N. Pavlidis
Acta Oncol. 2005;44(2):155-60


 

ADVANCED STAGE MUCINOUS EPITHELIAL dOVARIAN CANCER: THE HELLENIC COOPERATIVE ONCOLOGY GROUP EXPERIENCE
D. Pectasides, G. Fountzilas, G. Aravantinos, H.P. Kalofonos, E. Efstathiou, E. Salamalekis, D. Farmakis, D. Skarlos, E. Briasoulis, Th. Economopoulos, M.A. Dimopoulos
Gynecol Oncol. 2005 May;97(2):436-41


 

NON-HODGKIN'S LYMPHOMA IN GREECE ACCORDING TO THE WHO CLASSIFICATION OF LYMPHOID NEOPLASMS. A RETROSPECTIVE ANALYSIS OF 810 CASES
T. Economopoulos, S. Papageorgiou, M.A. Dimopoulos, N. Pavlidis, C. Tsatalas, A. Symeonidis, A. Foudoulakis, D. Pectasides, D. Rontogianni, E. Rizos, P. Chalkia, A. Anagnostopoulos, M. Melachrinou, E. Papageorgiou, G. Fountzilas
Acta Haematol. 2005;113(2):97-103


 

TREATMENT OF NON-SMALL CELL LUNG CANCER WITH GEFITINIB ("IRESSA", ZD1839): THE GREEK EXPERIENCE WITH A COMPASSIONATE-USE PROGRAM
E. Razis, D. Skarlos, E. Briasoulis, M. Dimopoulos, G. Fountzilas, S. Lambropoulos, S. Rigatos, P. Kopterides, H. Efstathiou, E. Tzamakou, C. Bakoyannis, D. Pectasides, T. Makatsoris, G. Varthalitis, S. Papadopoulos and P. Kosmidis
AntiCancer Drugs. 2005 Feb;16(2):191-8


 

IRINOTECAN OR OXALIPLATIN COMBINED WITH LEUCOVORIN AND 5-FLUOROURACIL AS FIRST-LINE TREATMENT IN ADVANCED COLORECTAL CANCER: A MULTICENTER, RANDOMIZED, PHASE II STUDY
H.P. Kalofonos, G. Aravantinos, P. Kosmidis, P. Papakostas, T. Economopoulos, M. Dimopoulos, D. Skarlos, A. Bamias, D. Pectasides, S. Chalkidou, M. Karina, A. Koutras, E. Samantas, C. Bacoyiannis, G.F. Samelis, G. Basdanis, F. Kalfarentzos and G. Fountzilas
Ann Oncol. 2005 Jun;16(6):869-77


 

PACLITAXEL, CISPLATIN, LEUCOVORIN, AND CONTINUOUS INFUSION FLUOROURACIL FOLLOWED BY CONCOMITANT CHEMORADIOTHERAPY FOR LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK. A HELLENIC COOPERATIVE ONCOLOGY GROUP PHASE II STUDY
G. Fountzilas, C. Tolis, A. Kalogera-Fountzila, D. Misailidou, P. Tsekeris, M. Karina, A. Nikolaou, E. Samantas, T. Makatsoris, E. Athanassiou, D. Skarlos, A. Bamias, N. Zamboglou, T. Economopoulos, S. Karanastassi, N. Pavlidis, and J. Daniilidis
Med Oncol. 2005;22(3):269-79


 

A PHASE II STUDY OF CAPECITABINE PLUS OXALIPLATIN (XELOX). A NEW FIRST-LINE OPTION IN METASTATIC COLORECTAL CANCER
T. Makatsoris, H.P. Kalofonos, G. Aravantinos, C. Papadimitriou, E. Kastritis, S. K. Rigatos, N. Xiros, T. Petsas, T. Economopoulos, A.K. Sakadamis, and G. Fountzilas
Int J Gastrointest Cancer. 2005;35(2):103-9


 

PROGNOSTIC FACTORS IN PATIENTS WITH COLORECTAL CANCER RECEIVING ADJUVANT CHEMOTHERAPY OR CHEMORADIOTHERAPY. A POOLED ANALYSIS OF TWO RANDOMIZED STUDIES
Bamias, G. Basdanis, I. Xanthakis, N. Pavlidis, and G. Fountzilas
Int J Gastrointest Cancer. 2005;36(1):29-38


 

ANGIOGENESIS IN CANCER OF UNKNOWN PRIMARY: CLINICOPATHOLOGICAL STUDY OF CD34, VEGF AND TSP-I
V. Karavasilis, V. Malamou-Mitsi, E. Briassoulis, E. Tsanou, E. Kitsou, H. P. Kalofonos, G. Fountzilas, T. Fotsis and N. Pavlidis
BMC Cancer. 2005 Mar 3;5:25


 

PACLITAXEL AND CARBOPLATIN AS FIRST-LINE CHEMOTHERAPY COMBINED WITH GEFITINIB (IRESSA) IN PATIENTS WITH ADVANCED BREAST CANCER: A PHASE I/II STUDY CONDUCTED BY THE HELLENIC COOPERATIVE ONCOLOGY GROUP
G. Fountzilas, D. Pectasides, A. Kalogera-Fountzila, D. Skarlos, H.P. Kalofonos, C. Papadimitriou, D. Bafaloukos, S. Lambropoulos, S. Papadopoulos, H. Kourea, C. Markopoulos, H. Linardou, D. Mavroudis, E. Briasoulis, N. Pavlidis, E. Razis, P. Kosmidis and H. Gogas
Breast Cancer Res Treat. 2005 Jul;92(1):1-9


 

INDUCTION CHEMOTHERAPY WITH CISPLATIN, EPIRUBICIN, AND PACLITAXEL (CEP), FOLLOWED BY CONCOMITANT RADIOTHERAPY AND WEEKLY PACLITAXEL FOR THE MANAGEMENT OF LOCALLY ADVANCED NASOPHARYNGEAL CARCINOMA. A HELLENIC COOPERATIVE ONCOLOGY GROUP PHASE II STUDY
G. Fountzilas, C. Tolis, A. Kalogera-Fountzila, C. Karanikiotis, M. Bai, D. Misailidou, E. Samantas, E. Athanassiou, D. Papamichael, P. Tsekeris, N. Catodritis, A. Nicolaou, G. Plataniotis, T. Makatsoris, P. Papakostas, N. Zamboglou, J. Daniilidis
Strahlentherapie Onkol. 2005 Apr;181(4):223-30


 

GEMCITABINE PLUS PEGYLATED LIPOSOMAL DOXORUBICIN IN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN CANCER RESISTANT/REFRACTORY TO PLATINUM AND/OR TAXANES. A HeCOG PHASE II STUDY
D. Skarlos, H.P. Kalofonos, G. Fountzilas, M.A. Dimopoulos, N. Pavlidis, E. Razis, T. Economopoulos, D. Pectasides, H. Gogas, P. Kosmidis, D. Bafaloukos, G. Klouvas, G. Kyratzis and G. Aravantinos
Anticancer Res. 2005 Jul-Aug;25(4):3103-8


 

IRINOTECAN AND OXALIPLATIN COMBINATION, AS SECOND-LINE TREATMENT, IN FLUOROPYRIMIDINE-PRETREATED ADVANCED COLORECTAL CANCER. A PHASE II STUDY BY THE HELLENIC COOPERATIVE ONCOLOGY GROUP (HeCOG)
E. Timotheadou, P. Papakostas, D. Tsavdaridis, G. Basdanis, H. Kalofonos, G. Aravantinos, D. Bafaloukos and G. Fountzilas
Tumori. 2005 Jul-Aug;91(4):309-13


 

TEMOZOLOMIDE AND CISPLATIN VERSUS TEMOZOLOMIDE IN PATIENTS WITH ADVANCED MELANOMA: A RANDOMIZED PHASE II STUDY OF THE HELLENIC COOPERATIVE ONCOLOGY GROUP
D. Bafaloukos, D. Tsoutsos, H. Kalofonos, S. Chalkidou, P. Panagiotou, E. Linardou, E. Briassoulis, E. Efstathiou, A. Polyzos, G. Fountzilas, C. Christodoulou, C. Kouroussis, T. Iconomou, H. Gogas
Ann Oncol. 2005 Jun;16(6):950-7


 

THE COMBINATION OF ESTRAMUSTINE, VINORELBINE, AND MITOXANTRONE IN HORMONE-REFRACTORY PROSTATE CANCER: A PHASE II FEASIBILITY STUDY CONDUCTED BY THE HELLENIC COOPERATIVE ONCOLOGY GROUP
G.F. Samelis, H.P. Kalofonos, A. Adamou, P. Kosmidis, D. Skarlos, G. Aravantinos, C. Kiamouris, A. Onyenadum, G. Fountzilas and A.M. Dimopoulos
Urology. 2005 Aug;66(2):382-5


 

MATRIX METALLOPROTEINASES IN CARCINOMA OF UNKNOWN PRIMARY
V. Karavasilis, V. Malamou-Mitsi, E. Briasoulis, E. Tsanou, E. Kitsou, H. Kalofonos, G. Fountzilas, T. Fotsis, PN. avlidis
Cancer. 2005 Nov 15;104(10):2282-7


 

A PHASE II STUDY OF THE DOCETAXEL-IFOSFAMIDE-CARBOPLATIN COMBINATION IN ADVANCED NON-SMALL-CELL LUNG CANCER
C. Kosmas, N. Tsavaris, A. Koutras, T. Makatsoris, N. Mylonakis, G. Tzelepis, A. Dimitrakopoulos, K. Spyropoulos, A. Polyzos, A. Karabelis, H.P. Kalofonos
Oncology. 2005;69(4):333-41


 

CARBOPLATIN PLUS GEMCITABINE IN PATIENTS WITH INOPERABLE OR METASTATIC PANCREATIC CANCER: A PHASE II MULTICENTER STUDY BY THE HELLENIC COOPERATIVE ONCOLOGY GROUP
N. Xiros, P. Papacostas, T. Economopoulos, G. Samelis, E. Efstathiou, E. Kastritis, H. Kalofonos, A. Onyenadum, D. Skarlos, A. Bamias, H. Gogas, D. Bafaloukos, E. Samantas, P. Kosmidis
Ann Oncol. 2005 May;16(5):773-9


 

PACLITAXEL PLUS CARBOPLATIN VERSUS PACLITAXEL PLUS ALTERNATING CARBOPLATIN AND CISPLATIN FOR INITIAL TREATMENT OF ADVANCED OVARIAN CANCER: LONG-TERM EFFICACY RESULTS: A HELLENIC COOPERATIVE ONCOLOGY GROUP (HeCOG) STUDY
G. Aravantinos, G. Fountzilas, P. Kosmidis, M.A Dimopoulos, G.P Stathopoulos, N. Pavlidis, D. Bafaloukos, C. Papadimitriou, S. Karpathios, V. Georgoulias, P. Papakostas, H.P Kalofonos, E. Grimani, D.V Skarlos
Ann Oncol. 2005 Jul;16(7):1116-22


 

BRAIN METASTASES FROM EPITHELIAL OVARIAN CANCER. THE HELLENIC COOPERATIVE ONCOLOGY GROUP (HeCOG) EXPERIENCE AND REVIEW OF THE LITERATURE
D. Pectasides, G. Aravantinos, G. ountzilas, C. Kalofonos, E. Efstathiou, M. Karina, N. Pavlidis, D. Farmakis, T. Economopoulos, M.A Dimopoulos
Anticancer Res. 2005 Sep-Oct;25(5):3553-8


 

PHASE I STUDY OF ETOPOSIDE, CISPLATIN, AND IRINOTECAN TRIPLET IN PATIENTS WITH ADVANCED-STAGE SMALL-CELL LUNG CANCER
E. Briasoulis, E. Samantas, H. Kalofonos, D. Skarlos, T. Makatsoris, C. Christodoulou, G. Fountzilas, A. Bamias, MA. Dimopoulos, P. Kosmidis, N. Pavlidis. Cancer Chemother Pharmacol. 2005 Nov;56(5):521-8


 

MULTIFOCAL EXTRANODAL NON-HODGKIN LYMPHOMA: A CLINICOPATHOLOGIC STUDY OF 37 CASES IN GREECE
T. Economopoulos, S. Papageorgiou, D. Rontogianni, V. Kaloutsi, G. Fountzilas, C. Tsatalas, N. Pavlidis, D. Pectasides, E. Papageorgiou, M. Dimopoulos
The Oncologist. 10(9): 734-8, 2005


 

hMSH2 IS THE MOST COMMONLY MUTATED MMR GENE IN A COHORT OF GREEK HNPCC PATIENTS
A Apessos, M Mihalatos, I Danielidis, G Kallimanis, NJ Agnantis, JK Triantafillidis, G Fountzilas, PA Kosmidis, E Razis, VA Georgoulias and G Nasioulas
Br J Cancer. 2005 Jan 31;92(2):396-404


 

CLINICAL AND MOLECULAR PROGNOSTIC FACTORS IN OPERABLE LARYNGEAL CANCER
K. Vlachtsis, A. Nikolaou, K. Markou, G. Fountzilas, I. Daniilidis
Eur Arch Otorhinolaryngol. 2005 Nov;262(11):890-8